PNS79 MONOPSONY BUYER: A CRITIQUE OF THE NATIONAL PHARMACEUTICAL PROGRAM PROPOSED FOR CANADA

Authors
Category Systematic review
JournalValue Health
Year 2020
This article has no abstract
Epistemonikos ID: efab6632971e499daef5634d1b7457b247b44797
First added on: May 20, 2020